Acorah Software Products - Accounts Production 16.2.850 false true false true No description of principal activity 22 May 2024 31 March 2025 31 March 2025 15725995 Mrs Fiona Brincat Dr Stephan Brincat iso4217:GBP iso4217:EUR iso4217:USD xbrli:shares xbrli:pure xbrli:pure 15725995 2024-05-21 15725995 2025-03-31 15725995 2024-05-22 2025-03-31 15725995 frs-core:CurrentFinancialInstruments 2025-03-31 15725995 frs-bus:PrivateLimitedCompanyLtd 2024-05-22 2025-03-31 15725995 frs-bus:FilletedAccounts 2024-05-22 2025-03-31 15725995 frs-bus:Micro-entities 2024-05-22 2025-03-31 15725995 frs-bus:AuditExempt-NoAccountantsReport 2024-05-22 2025-03-31 15725995 frs-bus:Director1 2024-05-22 2025-03-31 15725995 frs-bus:Director2 2024-05-22 2025-03-31
Registered number: 15725995
London Kidney Clinic Limited
Unaudited Financial Statements
For the Period 22 May 2024 to 31 March 2025
Sharpe Medical Accounting Ltd
Balance Sheet
Registered number: 15725995
31 March 2025
£
Fixed assets 2,279
Current assets 13,333
Creditors: Amounts Falling Due Within One Year (2,903 )
NET CURRENT ASSETS 10,430
TOTAL ASSETS LESS CURRENT LIABILITIES 12,709
Accruals and deferred income (720 )
NET ASSETS 11,989
CAPITAL AND RESERVES 11,989

Notes

1. General Information
London Kidney Clinic Limited is a private company, limited by shares, incorporated in England & Wales, registered number 15725995 . The registered office is Normanby Gateway, Lysaghts Way, Scunthorpe, DN15 9YG.
2. Average Number of Employees
Average number of employees, including directors, during the period was: 2
2
Page 0
Page 1
For the period ending 31 March 2025 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.
The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
These accounts have been prepared in accordance with the micro-entity provisions and delivered in accordance with the provisions applicable to companies subject to the small companies regime.
On behalf of the board
Mrs Fiona Brincat
Director
Dr Stephan Brincat
Director
25/04/2025